Chemokines as mediators of tumor angiogenesis and neovascularization.

Chemokines are a superfamily of structurally homologous heparin-binding proteins that influence tumor growth and metastasis. Several members of the CXC and CC chemokine families are potent inducers of neovascularization, whereas a subset of the CXC chemokines are potent inhibitors. In this paper, we review the current literature regarding the role of chemokines as mediators of tumor angiogenesis and neovascularization.

[1]  M. Burdick,et al.  Identification and Partial Characterization of a Variant of Human CXCR3 Generated by Posttranscriptional Exon Skipping1 , 2004, The Journal of Immunology.

[2]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[3]  A. Bikfalvi,et al.  Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. , 1998, Blood.

[4]  G. Doronzo,et al.  CCL16 activates an angiogenic program in vascular endothelial cells. , 2004, Blood.

[5]  M. Burdick,et al.  Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis , 2004, BMC Cancer.

[6]  M. Huang,et al.  SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10 , 2003, Molecular Cancer.

[7]  Borna Mehrad,et al.  Chemokines as Mediators of Neovascularization , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Burdick,et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.

[9]  M. Burdick,et al.  Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis , 2004, Circulation research.

[10]  Jeremy J. W. Chen,et al.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Y. Nakanishi,et al.  Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. , 1997, Cancer letters.

[12]  H. Gröne,et al.  Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  G. Gray,et al.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. , 1990, Science.

[14]  D. Ota,et al.  Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2* , 2003, The Journal of Biological Chemistry.

[15]  J. Singh,et al.  Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression , 1994, The Journal of cell biology.

[16]  Hiroshi Takamori,et al.  Autocrine Growth Effect of IL-8 and GRO&agr; on a Human Pancreatic Cancer Cell Line, Capan-1 , 2000, Pancreas.

[17]  Kyung Hee Hong,et al.  Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. , 2005, Blood.

[18]  J. Minna,et al.  High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. , 2006 .

[19]  M. Burdick,et al.  Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. , 2007, Cancer research.

[20]  D. Bostwick,et al.  Microvessel density in prostate cancer: prognostic and therapeutic utility. , 1998, Seminars in urologic oncology.

[21]  R. Rabin,et al.  Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.

[22]  R. Jain,et al.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis , 2004, Nature.

[23]  J. Loscalzo,et al.  The interaction of platelet factor four and glycosaminoglycans. , 1985, Archives of biochemistry and biophysics.

[24]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[25]  P. Kolattukudy,et al.  Monocyte Chemotactic Protein (MCP)-1 Promotes Angiogenesis via a Novel Transcription Factor, MCP-1-induced Protein (MCPIP)* , 2008, Journal of Biological Chemistry.

[26]  M. Burdick,et al.  CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer , 2004, Annals of the New York Academy of Sciences.

[27]  R. Strieter,et al.  Potential role for Duffy antigen chemokine‐binding protein in angiogenesis and maintenance of homeostasis in response to stress , 2002, Journal of leukocyte biology.

[28]  Sergio Romagnani,et al.  An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.

[29]  H. Kleinman,et al.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. , 1999, The American journal of pathology.

[30]  M. Burdick,et al.  Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10) , 2001, Cancer Immunology, Immunotherapy.

[31]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[32]  R. Strieter,et al.  Chemokines as mediators of angiogenesis , 2007, Thrombosis and Haemostasis.

[33]  N. Copeland,et al.  The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Burdick,et al.  CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. , 2005, American journal of respiratory and critical care medicine.

[35]  J. Hanna,et al.  Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. , 2003, Blood.

[36]  S. Homma,et al.  Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. , 2006, Journal of molecular and cellular cardiology.

[37]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[38]  B. Lévy,et al.  Post-ischaemic neovascularization and inflammation. , 2008, Cardiovascular research.

[39]  M. Moser.  Regulation of Th1/Th2 development by antigen-presenting cells in vivo. , 2001, Immunobiology.

[40]  J. Zieliński,et al.  Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. , 1998, European journal of gynaecological oncology.

[41]  C. Bucana,et al.  Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. , 1998, Journal of the National Cancer Institute.

[42]  P. Loetscher,et al.  Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.

[43]  A. Bikfalvi,et al.  The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules. , 2004, Seminars in thrombosis and hemostasis.

[44]  E. Hudson,et al.  Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  H. Augustin,et al.  Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1 , 1999, International journal of cancer.

[46]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[47]  M. Iannettoni,et al.  Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  M. Burdick,et al.  Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression , 1997, Journal of leukocyte biology.

[49]  Thomas C Chen,et al.  Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. , 2006, Neurosurgical focus.

[50]  Christian Weber,et al.  Importance of CXC Chemokine Receptor 2 in the Homing of Human Peripheral Blood Endothelial Progenitor Cells to Sites of Arterial Injury , 2007, Circulation research.

[51]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[52]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[53]  M. Serio,et al.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.

[54]  K. Pienta,et al.  Tumor-associated angiogenesis in prostate cancer. , 1993, Anticancer research.

[55]  R. Keep,et al.  CCL2 Regulates Angiogenesis via Activation of Ets-1 Transcription Factor1 , 2006, The Journal of Immunology.

[56]  C Murdoch,et al.  Cxc chemokine receptor expression on human endothelial cells. , 1999, Cytokine.

[57]  H. Matsubara,et al.  Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells , 2003, Circulation research.

[58]  Bernhard Moser,et al.  Lymphocyte traffic control by chemokines , 2001, Nature Immunology.

[59]  R. Schuster,et al.  The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  R. Figlin,et al.  The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma1 , 2005, The Journal of Immunology.

[61]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[62]  A. Bikfalvi.  Platelet factor 4: an inhibitor of angiogenesis. , 2004, Seminars in thrombosis and hemostasis.

[63]  H. Friess,et al.  Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. , 2006, Cancer letters.

[64]  M. Burdick,et al.  Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer1 , 2004, The Journal of Immunology.

[65]  Osamu Yoshie,et al.  Chemokine/chemokine receptor nomenclature. , 2003, Cytokine.

[66]  J. Ward,et al.  Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.

[67]  M. Teixeira,et al.  Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice , 2004, Inflammation Research.

[68]  A. Richmond,et al.  The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[69]  K. Tryggvason,et al.  Membrane Type 1-Matrix Metalloproteinase Is Regulated by Chemokines Monocyte-Chemoattractant Protein-1/CCL2 and Interleukin-8/CXCL8 in Endothelial Cells during Angiogenesis* , 2005, Journal of Biological Chemistry.

[70]  R. Strieter,et al.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer , 2006, The Journal of experimental medicine.

[71]  M. Burdick,et al.  Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1 , 2000, The Journal of Immunology.

[72]  M. Burdick,et al.  The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.

[73]  J. Finke,et al.  The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.

[74]  M. Burdick,et al.  CXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis1 , 2006, The Journal of Immunology.

[75]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[76]  I. Fidler,et al.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. , 2001, Neoplasia.